| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/05/2015 | WO2015031883A1 Hydrodynamic method and apparatus for delivering fluids to kidney tissues |
| 03/05/2015 | WO2015031871A1 Substituted urea depsipeptide analogs as activators of the clpp endopeptidase |
| 03/05/2015 | WO2015031837A1 Cell penetrating conjugates and methods of use thereof |
| 03/05/2015 | WO2015031819A1 Modularly assembled small molecules for the treatment of myotonic dystrophy type 1 |
| 03/05/2015 | WO2015031771A2 Administration of kynurenine depleting enzymes for tumor therapy |
| 03/05/2015 | WO2015031726A2 Engineered primate l-methioninase for therapeutic purposes |
| 03/05/2015 | WO2015031722A1 Method for treating amyotrophic lateral sclerosis by inhibition of cxcr4/cxcl12 signaling |
| 03/05/2015 | WO2015031709A1 Rapid acting injectable formulations comprising a peptide and a vasodilatory agent |
| 03/05/2015 | WO2015031654A2 Systems, compositions, and methods for transplantation and treating conditions |
| 03/05/2015 | WO2015031541A1 Novel sez6 modulators and methods of use |
| 03/05/2015 | WO2015031465A1 Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same |
| 03/05/2015 | WO2015031412A1 Testosterone booster transdermal compositions |
| 03/05/2015 | WO2015031381A1 Cyclosporin analogues for preventing or treating hepatitis c |
| 03/05/2015 | WO2015031316A1 Methods of using interleukin-10 for treating diseases and disorders |
| 03/05/2015 | WO2015031084A1 Methods of synthesizing y-aapeptides, y-aapeptide building blocks, y-aapeptide libraries, and y-aapeptide inhibitors of ab40 aggregates |
| 03/05/2015 | WO2015030628A2 Application of yb-1 protein and fragments thereof for preparing medicinal agents in treating alzheimer's disease |
| 03/05/2015 | WO2015028892A2 Reaction platform and method for making pollen based materials in combination with beeswax and uses thereof |
| 03/05/2015 | WO2015028831A1 Cxcl12 (chemokine (c-x-c motif) ligand 12) and igfbp2 inhibitors for the application in the treatment of diabetes mellitus associated pancreatic cancer |
| 03/05/2015 | WO2015028558A1 Stable polypeptides binding to human complement c5 |
| 03/05/2015 | WO2015028173A1 Lactoferrin and memory and learning speed in children |
| 03/05/2015 | WO2015028104A1 Novel drug combination |
| 03/05/2015 | WO2015027959A1 Cyclic peptide compound, and preparation method, pharmaceutical composition and use thereof |
| 03/05/2015 | WO2015027906A1 Bifunctional fusion protein, preparation method therefor, and use thereof |
| 03/05/2015 | WO2015027342A1 Microgel compositions for delivery of substances to the brain |
| 03/05/2015 | WO2015027322A1 Methods and compositions for treatment of cartilage and disc tissue pathologies |
| 03/05/2015 | US20150065833 Analyte Sensors Comprising High-Boiling Point Solvents |
| 03/05/2015 | US20150065685 Laser-actuated therapeutic nanoparticles |
| 03/05/2015 | US20150065684 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 03/05/2015 | US20150065432 Visfatin therapeutic agents for the treatment of acne and other conditions |
| 03/05/2015 | US20150065431 Reducing cutaneous scar formation and treating skin conditions |
| 03/05/2015 | US20150065430 Process for manufacturing collagen and trace elements from sea water |
| 03/05/2015 | US20150065427 Modulation of osteoclast differentiation |
| 03/05/2015 | US20150065426 Testosterone Booster Transdermal Compositions |
| 03/05/2015 | US20150065424 Vip fragments and methods of use |
| 03/05/2015 | US20150065423 Rapid acting injectable formulations |
| 03/05/2015 | US20150065422 Substituted diketopiperazine analogs for use as drug delivery agents |
| 03/05/2015 | US20150065421 Basal insulin therapy |
| 03/05/2015 | US20150065420 Vitamin d-ghrelin conjugates |
| 03/05/2015 | US20150065419 Methods for treating metabolic disorders using fgf |
| 03/05/2015 | US20150065418 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 03/05/2015 | US20150065417 High purity cyclopeptide compound as well as preparation method and use thereof |
| 03/05/2015 | US20150065416 Novel drug combination |
| 03/05/2015 | US20150065414 Modified toll-like receptor 2 (tlr2) ligands as inhibitors of neutrophil recruitment |
| 03/05/2015 | US20150064284 Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds |
| 03/05/2015 | US20150064267 Nanoparticles for controlled lysis of blood clots |
| 03/05/2015 | US20150064265 Vehicles for Controlled Delivery of Different Pharmaceutical Agents |
| 03/05/2015 | US20150064255 Nanostructures for treating cancers and other conditions |
| 03/05/2015 | US20150064239 Methods for identifying modulators of il-24 mediated apoptosis and immunotherapy |
| 03/05/2015 | US20150064236 Modified polynucleotides for the production of proteins |
| 03/05/2015 | US20150064183 Targeted therapeutic proteins |
| 03/05/2015 | US20150064167 Method for treating premature ejaculation with a botulinum neurotoxin |
| 03/05/2015 | US20150064166 Lyophilized Preparation of Botulinum Toxin |
| 03/05/2015 | US20150064165 Devices and methods for reducing the appearance of cellulite |
| 03/05/2015 | US20150064163 BMP Peptides & Methods of Use |
| 03/05/2015 | US20150064162 Marketing the use of an acidic soft drink to enhance the efficacy of a gluten-digesting enzyme |
| 03/05/2015 | US20150064161 Pharmacological vitreolysis |
| 03/05/2015 | US20150064160 Engineered primate cystine/cysteine degrading enzymes as antineogenic agents |
| 03/05/2015 | US20150064159 Engineered primate l-methioninase for therapeutic purposes |
| 03/05/2015 | US20150064154 Administration of kynurenine depleting enzymes for tumor therapy |
| 03/05/2015 | US20150064137 Use of engineered viruses to specifically kill senescent cells |
| 03/05/2015 | US20150064136 Predictors of patient response to interferon-a therapy |
| 03/05/2015 | US20150064135 Agent for the treatment of viral hepatitis c |
| 03/05/2015 | US20150064134 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| 03/05/2015 | US20150064133 Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same |
| 03/05/2015 | US20150064132 Treatment Methods for Rheumatoid Arthritis |
| 03/05/2015 | US20150060462 Portable neurotoxin injection tray and associated apparatus, system, and method |
| 03/05/2015 | DE102013014651A1 Zubereitungen zur verbesserten Gewebe-Oxygenierung durch peritoneale Beatmung Preparations for improved tissue oxygenation by peritoneal ventilation |
| 03/04/2015 | EP2843048A1 NOVEL INTEGRIN alpha9beta1 LIGAND AND USES THEREOF |
| 03/04/2015 | EP2842969A1 Lactoferrin fusion protein and method for producing same |
| 03/04/2015 | EP2842966A1 Therapeutic agent for injury in epithelium and endothelium |
| 03/04/2015 | EP2842576A1 Transglutaminase mediated conjugation of peptides |
| 03/04/2015 | EP2842575A1 Auristatin drug linker conjugates |
| 03/04/2015 | EP2842574A1 Sustained release carrier for drugs |
| 03/04/2015 | EP2842568A1 Pharmaceutical composition for treating and/or preventing type i diabetes and application thereof |
| 03/04/2015 | EP2842567A1 Composition for controlled ovarian stimulation |
| 03/04/2015 | EP2842566A1 Use of arpin a new inhibitor of the arp2/3 complex for the diagnosis and treatment of diseases |
| 03/04/2015 | EP2842565A1 Antibody-mediated disruption of quorum sensing in bacteria |
| 03/04/2015 | EP2841451A1 Compounds suitable for treatment of haemophilia |
| 03/04/2015 | EP2841449A2 Archease as rna ligase complex member |
| 03/04/2015 | EP2841448A1 Par4 agonist peptides |
| 03/04/2015 | EP2841101A1 Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
| 03/04/2015 | EP2841096A2 Antigens and antigen combinations |
| 03/04/2015 | EP2841092A1 Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients |
| 03/04/2015 | EP2841091A1 Pharmaceutical composition suitable for treatment of haemophilia |
| 03/04/2015 | EP2841090A1 Site-specific enzymatic modification of exendins and analogs thereof |
| 03/04/2015 | EP2841089A1 Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders |
| 03/04/2015 | EP2841088A2 Use of thymosin alpha for the treatment of sepsis |
| 03/04/2015 | EP2841087A1 Vascular endothelial growth factor antagonists and methods for their use |
| 03/04/2015 | EP2841086A1 Compositions and methods for inhibiting the activity of lar family phosphatases |
| 03/04/2015 | EP2841085A1 Anti-oomycete activity of lipopolysaccharide (lps)-binding proteins/bactericidal/permeability-increasing proteins |
| 03/04/2015 | EP2841084A1 Peptides and use thereof in the treatment of large cell lung cancer |
| 03/04/2015 | EP2841083A1 Bis-polymer lipid-peptide conjugates and nanoparticles thereof |
| 03/04/2015 | EP2841082A1 Protease-regulated antibodies |
| 03/03/2015 | US8969538 Albumin fusion proteins |
| 03/03/2015 | US8969529 Methods and compositions based on shiga toxin type 2 protein |
| 03/03/2015 | US8969524 FVIII peptides for immune tolerance induction and immunodiagnostics |
| 03/03/2015 | US8969523 Sebum secretion-blocking composition, and food or beverage containing same |
| 03/03/2015 | US8969522 Method for producing collagen-like polypeptide |
| 03/03/2015 | US8969519 Compositions and methods for brown fat induction and activity using FNDC5 |
| 03/03/2015 | US8969515 Pharmaceutical composition for treating hyperproliferative diseases |